Baclofen for Back Pain: Limited Evidence and Questionable Efficacy
Based on the highest quality evidence, baclofen shows minimal to no benefit for back pain relief, and when studied, patients typically took the medication for 1-2 weeks (30 mg daily titrated up to 80 mg daily) before any potential benefit was assessed—though even then, the evidence suggests it provides no meaningful advantage over placebo or NSAIDs alone 1.
The Evidence Against Baclofen for Back Pain
Most Recent High-Quality Trial (2019)
The strongest and most recent evidence comes from a randomized, placebo-controlled trial in acute low back pain 1. Patients received:
- Dosing regimen: Baclofen 10 mg, taken 1-2 capsules three times daily as needed for 1 week
- Result: No difference in functional improvement or pain reduction compared to ibuprofen plus placebo
- At 1-week follow-up, 33% of baclofen patients still had moderate-to-severe pain versus 30% in the placebo group—essentially identical outcomes
Guideline Recommendations
Major clinical practice guidelines do not recommend baclofen for back pain 2. The 2017 American College of Physicians systematic review for low back pain management extensively evaluated muscle relaxants but found:
- Skeletal muscle relaxants (as a class) showed benefit only for acute low back pain at 2-4 days and 5-7 days
- Evidence for chronic low back pain was insufficient with inconsistent results
- Baclofen specifically is mentioned only in the context of neuropathic pain, not musculoskeletal back pain 3
Historical Context (1985 Study)
An older trial from 1985 evaluated baclofen 30-80 mg daily for 14 days in acute low-back syndrome 4. While it reported some benefit, this study:
- Predates modern evidence standards
- Is contradicted by the more rigorous 2019 trial
- Showed significantly higher adverse effects in the baclofen group
Clinical Reality: Baclofen Is Not Indicated for Back Pain
What Baclofen Actually Treats
Baclofen is a GABA-B agonist primarily indicated for:
- Spasticity (particularly in spinal cord injury) 5
- Neuropathic pain in specific contexts (intrathecal administration for SCI-related neuropathic pain) 6
- Trigeminal neuralgia (anecdotal) 3
Why It Doesn't Work for Mechanical Back Pain
Back pain is typically musculoskeletal or neuropathic (radicular), not spastic. The mechanism of baclofen (reducing spasticity through GABA-B agonism) doesn't address the underlying pathophysiology of common back pain.
Safety Concerns in Practice
Baclofen carries significant risks, particularly in older adults 7:
- Increased fall risk compared to tizanidine (68% higher risk)
- Central nervous system adverse effects: somnolence, dizziness, sedation 2
- Risk of withdrawal seizures and hallucinations with abrupt discontinuation 8
- Requires dose reduction in renal impairment 8
The Bottom Line Algorithm
For acute non-radicular low back pain:
- Start with NSAIDs (ibuprofen 600 mg three times daily as needed)
- If muscle relaxation is needed, consider other skeletal muscle relaxants (though evidence is marginal)
- Do not use baclofen—no evidence of benefit over placebo when added to NSAIDs 1
For chronic back pain:
- Baclofen has insufficient evidence and should not be used 2
- Consider guideline-recommended therapies (physical therapy, duloxetine for neuropathic component, topical NSAIDs)
For radicular pain (sciatica):
- Baclofen showed no benefit and was actually inferior to placebo in one trial 2
- Use gabapentinoids (gabapentin or pregabalin) as first-line adjuvants if neuropathic component 3
Common Pitfall to Avoid
Do not confuse "muscle relaxant" classification with clinical efficacy. Just because baclofen relaxes muscles doesn't mean it helps back pain—the 2019 trial definitively showed no benefit over placebo when combined with NSAIDs 1.